glp-1 coverage news Insurance just changed for as many as 56 million Americans when it comes to the popular medications used to promote weight loss. https://www.wfla.com/news/national/glp-1-insurance-change-impacts-millions-of-americans-what-to-know-how-to Perspectives from employers on the

Berberine (BBR) exhibits significant anti-diabetic effects by enhancing insulin sensitivity, promoting glycolysis, and inhibiting gluconeogenesis

Mercedez Hernandez walks through what patients should consider when weighing their options.

The CEO of the Alliance for Pharmacy Compounding unpacks how the ruling affects telehealth providers and what it could signal for future GLP-1 entrants and market dynamics:

Adipogen Life Sciences

Exposures Two cohorts were assembled, with the first composed of patients who started and continued on GLP-1 receptor agonists or DPP-4 inhibitors between 1 January 2007 and 31 December 2020 and the second composed of patients who started and continued on GLP-1 receptor agonists or SGLT-2 inhibitors between 1 January 1 2013 and 31 December 2020

With the rising incidence of obesity, there is a growing demand for new therapies which can effectively manage body weight and improve health